Kite Pharma, Inc. KITE
No live quote for KITE yet.
Valuation
P/E 0.0×
FY 2014 5y median 0.0× FY 2016
P/S 0.0×
FY 2014 5y median 0.0× FY 2016
P/B 0.0×
FY 2014 5y median 0.0× FY 2016
P/FCF 0.0×
FY 2014 5y median 0.0× FY 2016
EV/EBITDA 0.3×
FY 2014 5y median 3.9× FY 2016
EV/Sales -3.8×
FY 2014 5y median -3.8× FY 2016
FCF Yield 0.0%
FY 2014 5y median 0.0% FY 2016
Profitability
Gross Margin 100.0%
FY 2014 5y median 100.0% FY 2016
Operating Margin -1232.2%
FY 2014 5y median -598.7% FY 2016
Net Margin -1204.6%
FY 2014 5y median -589.0% FY 2016
ROE -62.4%
FY 2014 5y median -16.5% FY 2016
ROIC -57.5%
FY 2014 5y median -15.4% FY 2016
ROA -50.9%
FY 2014 5y median -14.4% FY 2016
Growth (YoY)
Revenue 28.5%
FY 2014 FY 2016
Operating Income -164.4%
FY 2014 FY 2016
EPS (diluted) -137.3%
FY 2014 FY 2016
Free Cash Flow -343.2%
FY 2014 FY 2016
Financial Health
Current Ratio 7.8×
FY 2014 5y median 17.4× FY 2016
Quick Ratio 7.8×
FY 2014 5y median 17.4× FY 2016
Debt / Equity 0.1×
FY 2014 5y median 0.0× FY 2016
Net Debt / EBITDA 0.3×
FY 2014 5y median 3.9× FY 2016
Interest Coverage -21014×
FY 2014 5y median -157× FY 2016
Dividends
Dividend Yield 0.0%
FY 2014 5y median 0.0% FY 2016
Payout Ratio 0.0%
FY 2014 5y median 0.0% FY 2016
Annual · latest fiscal year ends 2016-12-31